These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 17010016)
1. EDTA-induced urothelial cell shedding for the treatment of superficial bladder cancer in the mouse. Nativ O; Dalal E; Hidas G; Aronson M Int J Urol; 2006 Oct; 13(10):1344-6. PubMed ID: 17010016 [TBL] [Abstract][Full Text] [Related]
2. [A simple and efficient method for establishing a mouse model of orthotopic MB49 bladder cancer]. Liang ZK; Zhang L; Hu ZM; Chen Z; Huang X; Shi XH; Tan WL; Gao JM Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):627-30. PubMed ID: 19403380 [TBL] [Abstract][Full Text] [Related]
4. Optimizing orthotopic bladder tumor implantation in a syngeneic mouse model. Chan ES; Patel AR; Smith AK; Klein JB; Thomas AA; Heston WD; Larchian WA J Urol; 2009 Dec; 182(6):2926-31. PubMed ID: 19846165 [TBL] [Abstract][Full Text] [Related]
5. [A new animal model for intravesical chemotherapy of bladder cancer]. Yamashita T; Ito J Gan To Kagaku Ryoho; 1988 Jul; 15(7):2087-92. PubMed ID: 2456038 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall. Olbert PJ; Schrader AJ; Simon C; Dalpke A; Barth P; Hofmann R; Hegele A Anticancer Res; 2009 Jun; 29(6):2067-76. PubMed ID: 19528466 [TBL] [Abstract][Full Text] [Related]
7. Antitumoral effect of recombinant mistletoe lectin on chemically induced urinary bladder carcinogenesis in a rat model. Elsässer-Beile U; Ruhnau T; Freudenberg N; Wetterauer U; Mengs U Cancer; 2001 Mar; 91(5):998-1004. PubMed ID: 11251952 [TBL] [Abstract][Full Text] [Related]
8. Curcumin prevents intravesical tumor implantation of the MBT-2 tumor cell line in C3H mice. Sindhwani P; Hampton JA; Baig MM; Keck R; Selman SH J Urol; 2001 Oct; 166(4):1498-501. PubMed ID: 11547120 [TBL] [Abstract][Full Text] [Related]
9. Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice. Pfost B; Seidl C; Autenrieth M; Saur D; Bruchertseifer F; Morgenstern A; Schwaiger M; Senekowitsch-Schmidtke R J Nucl Med; 2009 Oct; 50(10):1700-8. PubMed ID: 19793735 [TBL] [Abstract][Full Text] [Related]
11. Enhanced cytologic detection of early stage mouse bladder tumor following induction of uroepithelial cell shedding. Nativ O; Medalia O; Engelberg S; Raviv G; Aronson M J Urol; 1994 Jul; 152(1):217-9. PubMed ID: 8201669 [TBL] [Abstract][Full Text] [Related]
12. Microscopic quantification of hypercin fluorescence in an orthotopic rat bladder tumor model after intravesical instillation. Kamuhabwa AA; Roskams T; Baert L; De Witte PA Int J Oncol; 2003 Apr; 22(4):933-7. PubMed ID: 12632090 [TBL] [Abstract][Full Text] [Related]
13. [Intravesical perfusion of recombinant adeno-associated virus-endostatin in treatment of bladder cancer: experiments with mice]. Lu BX; Han RF; Tang Y; Lei MD; Li SZ Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(44):3157-8. PubMed ID: 19159603 [TBL] [Abstract][Full Text] [Related]
14. In vivo retroviral mediated gene transfer into bladder urothelium results in preferential transduction of tumoral cells. Dumey N; Mongiat-Artus P; Devauchelle P; Lesourd A; Cotard JP; Le Duc A; Marty M; Cussenot O; Cohen-Haguenauer O Eur Urol; 2005 Feb; 47(2):257-63. PubMed ID: 15661423 [TBL] [Abstract][Full Text] [Related]
15. In vivo studies on the availability and toxicity of antisense oligonucleotides in bladder cancer. Blietz CE; Thode B; Hauses M; Pries R; Meyer AJ; Doehn C; Jocham D; Kausch I In Vivo; 2009; 23(1):13-9. PubMed ID: 19368119 [TBL] [Abstract][Full Text] [Related]
16. An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies. Watanabe T; Shinohara N; Sazawa A; Harabayashi T; Ogiso Y; Koyanagi T; Takiguchi M; Hashimoto A; Kuzumaki N; Yamashita M; Tanaka M; Grossman HB; Benedict WF Cancer Gene Ther; 2000 Dec; 7(12):1575-80. PubMed ID: 11228536 [TBL] [Abstract][Full Text] [Related]
17. Intravesical therapy with vinorelbine tartrate: antitumor activity in orthotopic murine cell carcinoma of the bladder. Bonfil RD; Russo DM; Schmilovich AJ; Garcia-Palazzo IB J Urol; 1997 Sep; 158(3 Pt 1):912-5. PubMed ID: 9258118 [TBL] [Abstract][Full Text] [Related]
18. Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer. Hadaschik BA; Zhang K; So AI; Fazli L; Jia W; Bell JC; Gleave ME; Rennie PS Cancer Res; 2008 Jun; 68(12):4506-10. PubMed ID: 18559493 [TBL] [Abstract][Full Text] [Related]
19. Prevention of bladder tumor formation in mice by a novel bone marrow-derived factor, reptimed. Khandaker MH; Kadhim SA; Ichim TE; Howson-Jan K; Chin J; Singhal SK Anticancer Res; 2000; 20(1A):183-9. PubMed ID: 10769653 [TBL] [Abstract][Full Text] [Related]
20. In vitro modulation of implantation and intraepithelial expansion of bladder tumor cells by epidermal growth factor. Bindels EM; Vermey M; Rebel JM; Zwarthoff EC; Van Der Kwast TH Exp Cell Res; 1997 Sep; 235(2):395-402. PubMed ID: 9299164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]